Translumina Therapeutics is manufacturing Yukon Choice PC, Sirolimus Eluting Coronary Stent System for the treatment of Coronary Artery disease for both domestic and international market. Yukon Choice PC manufactured by us is CE certified. Translumina Therapeutics LLP is ISO 9001:2008, ISO 13485:2003, ISO 14001:2004, OHSAS 18001:2007 and WHO GMP certified. Translumina Therapeutics under technology transfer from renowned European cardiac institute gives us cutting edge technology to produce world class Drug Eluting Stents comparable to best in the industry at state of art plant situated in Parma city, Selaqui, Dehradun, India.